Did you know that MyRisk? + RiskScore? is a comprehensive #breastcancer risk assessment tool validated for women of all ancestries and incorporates breast density? ?? Learn more at www.getmyrisk.com. #genetictesting #healthcareprofessionals #breastcancerawarenessmonth
Myriad Genetics
生物技术研究
Salt Lake City，Utah 86,759 位关注者
We're a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.
关于我们
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.
- 网站
-
https://www.myriad.com/
Myriad Genetics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 1,001-5,000 人
- 总部
- Salt Lake City，Utah
- 类型
- 上市公司
- 创立
- 1991
- 领域
- Molecular Diagnostics、Personalized Medicine、Prognostic Medicine、Companion Diagnostics、Carrier Screen、Pharmacogenomics、Genetic Testing、Hereditary Cancer、Prostate Cancer、Breast Cancer、Prenatal Screen、Precision Medicine、Ovarian Cancer、Pancreatic Cancer和Gender Testing
地点
Myriad Genetics员工
动态
-
This week, our South San Francisco office came together for an important cause - raising awareness for #breastcancer ??. Thank you Samantha Ganz for sharing highlights from the breast cancer awareness walk and the inspiring activities teammates participated in. At Myriad Genetics, we understand the importance of community and support. By joining forces this week in South San Francisco, we walk not only in solidarity with those affected by breast cancer but to also amplify the message of hope, courage, early detection and informed care. Together, we can make a difference. ?? #breastcancerawareness #teamMyriad
Walking with one another means more than an afternoon stroll. At Myriad Genetics, we walk together to remind eachother we are not alone. Our South San Francisco office took the opportunity to wear pink, unite, and raise awareness?for breast cancer, early detection, and supported one another to live an active lifestyle. We decorated pink pumpkins to honor survivors, remember those lost, and empower one another to continue to the fight against breast cancer. With over 30 years of experience in actionable genetic insights, Myriad Genetics is your trusted partner in precision medicine. MyRisk is more than a test. The MyRisk Hereditary Cancer Test provides fast and comprehensive results to help inform treatment decisions for patients with cancer, and accurately stratifies risk to create personalized medical management plans for those with a high risk of developing cancer. MyRisk is designed for surgeons treating patients diagnosed with or at risk for: * Breast cancer* * Ovarian cancer * Prostate cancer * Pancreatic cancer* * Uterine cancer * Colorectal cancer * Skin cancer * Gastric cancer * Renal cancer * Lung cancer * Endocrine cancer I challenge you to be apart of something bigger than yourself. ?? Thank you to all my amazing colleagues who participated in SSF. Excited to see this walk continue through the entire month of October! We’re stronger together! Ashley Perea Steve Cattich Marilu Soriano Tilley Shane Brubaker Estela Rudd Kevin Haas Rosina Gabriel Imiru Benjamin Obadia Stephen Wells Shereen Solaiman Samuel Pearlman Helen Wan Hazel Marte Bianca Miani Noah Tull Anwesh T. Mike Facio Molly Brannick (she/her) Paula Esquetini Yash Patel Matias Pyle #breastcancerawareness #hope #courage #strength #pink #genetictesting #teamwork #myriad
-
New American Society of Clinical Oncology (ASCO) guidelines recommend clinicians pair #germline and #genomic testing to determine the best treatment options for #breastcancer patients. Why? ?? Up to 10% of germline positive results can be missed by tumor testing alone.* ?? With genetic and genomic testing, providers can guide personalized and specific treatment. ?? When genetic and genomic testing are both done at one lab, with one workflow, it ensures consolidated concordant results. Learn why MyRisk(R) and Precise Tumor(R) testing together provide a more complete picture: https://lnkd.in/gtXyNaSr #breastcancerawarenessmonth #precisionmedicine #ASCO #genetictesting #cancerguidelines #genomictesting *Tung N, Ricker C, Messersmith H, et al. Selection of Germline Genetic Testing Panels in Patients With Cancer: ASCO Guideline. J. Clin. Oncol. Published online May 17, 2024. doi:https://lnkd.in/gG2tbWwy.
-
-
Thank you GenomeWeb for highlighting our research collaborations to study the use of #MRD testing in #breastcancer! Learn more: https://lnkd.in/gpUv8j6T.
The company is studying the use of its Precise MRD test in the breast cancer setting. It also said it estimates between $210 million and $212 million in Q3 revenue.
-
?? Happy National Customer Service Appreciation Week to our Customer Service leaders and teammates in hereditary cancer, mental health, prenatal and tissue! We celebrate our Customer Service team for the passion, dedication and exceptional service they bring to #teamMyriad each day. The impact on the patients, families and clinicians we serve through the work they do is the backbone of our success. Thank you for your invaluable contributions and your commitment to assisting our customers with empathy, patience and professionalism! ?? #aboveandbeyond #customerservice #teamwork #companyculture
-
-
Today, we announced a series of ongoing research collaborations to study the use of molecular residual disease (MRD) testing in breast cancer using our Precise? MRD test. Learn more: https://lnkd.in/gpUv8j6T #breastcancer #mrd #innovation
-
-
Could guesstimating risk put some patients at risk? A comprehensive assessment using MyRisk? with RiskScore? can examine clinical, hereditary and even personalized genetic risks - all in one. Learn more at www.getmyrisk.com. #genetictesting #hereditarycancer #breastcancerawareness
-
-
?? We appreciate all the healthcare providers who work tirelessly and are committed to guiding patients through every step of their breast cancer journey – during #BreastCancerAwarenessMonth and all other months. ?? At Myriad, we’re here to partner with you by delivering actionable genetic and genomic insights that help illuminate risk and improve treatment options for breast cancer patients. The MyRisk? Hereditary Cancer Test and Precise Tumor? genomic profiling test provide you with the accuracy and precision needed to make confident, informed decisions that lead to better patient outcomes. See how we support healthcare providers like you with genetic and genomic testing: https://lnkd.in/gHcfzBf3. #BreastCancer #genetictesting #genomictesting #precisionmedicine
-
-
?? Exciting times at Myriad Genetics! This week, our Business Unit Marketing and Enterprise Marketing teams joined together in #Chicago for a dynamic Marketing Summit. This #event provided a fantastic opportunity to align on our priorities for 2025 and beyond while strengthening the connections across our teams. We participated in insightful presentations and collaborative sessions, but it wasn't just about strategy - our teams also took time to give back! We had the privilege of assembling care packages for Ronald McDonald House Charities of Chicagoland & Northwest Indiana and were proud to help support families during challenging times. Thank you to Mark Verratti for joining the Summit and inspiring our teams to charge forward; our official host Glenn Farrell; our #marketing teams for coming together for an energetic, productive meeting; and to our wonderful events team for making the magic happen! ?? #teamMyriad #marcom #marketingdigital #communications
-
-
Today we announced alongside Ultima Genomics, Inc., a developer of a revolutionary new ultra-high throughput next generation sequencing (NGS) platform, a joint effort to explore Ultima's UG 100? sequencing platform and its ppmSeq? technology to advance Myriad's ability to offer groundbreaking clinical tests. Learn more: https://lnkd.in/g26gi97e #innovation #technology
-